Brussels, 31/07/2003 (Agence Europe) - The European Commission has sent a Statement of Objections to the Anglo-Swedish group AstraZeneca for alleged misuse of rules and procedures in order to extend protection for its Losec product, which led to the investigation proceedings. Mario Monti explained that, “This is not about the use or enforcement of patent rights which are necessary and even indispensable to foster a competitive European research-based pharmaceutical industry. It is about...